Target intelligence / Profile preview

WHAMM pseudogene 4 (WHAMMP4)

Target
WHAMMP4
Molecular classification
Other (Pseudogene)
01

Overview

WHAMM pseudogene 4 (WHAMMP4) is a nonfunctional DNA sequence—a pseudogene—that resembles the functional WHAMM gene but has lost the ability to produce a functional protein product due to disabling mutations or lack of regulatory elements. Pseudogenes like WHAMMP4 are the byproducts of evolutionary processes such as gene duplication or retrotransposition and are typically classified as "junk DNA," although some pseudogenes can give rise to non-coding RNAs involved in genetic regulation in rare cases. There is no evidence that WHAMMP4 has any biological function, relevance to disease, or role as a therapeutic target, and it is not associated with any drugs or biomarkers.

02

Mechanism of action

None known

03

Biological functions

None established; typical functions for pseudogenes may include acting as non-coding RNAs or microRNA sponges, but there is no evidence for this specific pseudogene
04

Disease associations

None known
05

Safety considerations

None known
06

Interacting drugs

None known
07

Biomarkers

None known

Beyond the preview

Go deeper on WHAMM pseudogene 4 (WHAMMP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on WHAMM pseudogene 4 (WHAMMP4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call